Source link : https://news.google.com/rss/articles/CBMiwwFBVV95cUxPdENLRkxhc0tBaFd3UElaZFZCZm5LRFVyeXRiZWJBcTY1LXY2YzVtaUk0U2FxX1NfalM0MkNxMEdmTWJHSEh0SHFPUGFBYUdNZmdZbDBJa1NsWEVmUDdmc3gtVjFVV2E3MDZvRW9zUEhHaEZXRHR0NmxRUlRGVE5LNENaYU05Q0JCU3ZyV3JpWW1HLVBwRjJGcXZ0UGhiRHFrUVdwZ1ZOUkhkNlhyRTR6TDlaeTR2UEtzbUVHVUxRSUhRdVk?oc=5
Author :
Publish date : 2025-01-31 12:24:00
Copyright for syndicated content belongs to the linked Source.
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union – Biogen | Investor Relations
